Gary Marshall Gary Marshall

BioRender in Dimension Capital’s investment at a $900-million valuation

On December 18, 2025, BioRender announced that it facilitated a secondary purchase by Dimension Capital at a $900-million valuation. BioRender is a web-based platform that crafts and shares visually engaging scientific figures for communication and publication purposes. Osler, Hoskin &...

Lead Office: Toronto Date Announced: December 18, 2025 Value: $900 million

Genesys Capital in Enspire DBS Therapy’s $10.3-million Series B1 financing

On January 13, 2026,  Enspire DBS Therapy, Inc. announced that it raised $10.3 million in a Series B1 financing led by Genesys Capital. It also saw participation from existing investors Cleveland Clinic and JobsOhio Ventures. Genesys Capital invests in and builds companies in the...

Lead Office: Toronto Date Announced: January 13, 2026 Value: $10.3 million

Impression Ventures in 401GO’s $33-million Series B financing

On December 9, 2025, 401GO announced it raised $33 million of Series B Financing in a round that was led by Centana Growth Partners and had participation from Impression Ventures, Next Frontier Capital and Rally Ventures. Impression Ventures is a Toronto-based venture capital firm that invests...

Lead Office: Toronto Date Announced: December 9, 2025 Value: $33 million

AmacaThera in its licensing agreement with Pacira Biosciences for US$230 million

On November 4, 2025, AmacaThera announced that it signed an exclusive global licensing agreement with Pacira Biosciences for up to US$230 million, validating its tunable drug delivery platform. AmacaThera is a leading developer of next-generation hydrogel-based drug delivery solutions. Using a...

Lead Office: Toronto Date Announced: November 4, 2025 Value: US$230 million

Genesys Capital in connection with Antegrade Medical’s $7.3-million Series Seed financing

On October 28, 2025,  Antegrade Medical Inc. announced the closing of a $7.3-million Series Seed financing. The financing was led by Sectoral Asset Management and had participation from Genesys Capital, Desjardins Capital, Seido Capital and private investors. Genesys Capital invests in and...

Lead Office: Toronto Date Announced: October 28, 2025 Value: $7.3 million

Kompliant in its acquisition by LegitScript

On October 27, 2025, Kompliant Inc. announced that it was acquired by LegitScript. This acquisition enhances LegitScript’s position as a leading provider of risk intelligence and compliance solutions. Kompliant Inc. is an emerging platform designed for financial institutions. Osler,...

Lead Office: Toronto Date Announced: October 27, 2025 Value: --

Ridge Ventures in its lead investment in Tato’s $5-million Seed financing

On October 1, 2025, Tato announced that it raised $5 million in a seed financing round led by Ridge Ventures. Other investors in the round included Myriad Venture Partners, Betaworks and RRE Ventures. Ridge Ventures is a seed and early-stage venture capital firm. Osler, Hoskin &...

Lead Office: Toronto Date Announced: October 1, 2025 Value: $5 million

CoVet in its securing of growth funding

On September 2, 2025, CoVet announced it closed a growth funding round with Off Leash Capital. This investment will accelerate CoVet’s global expansion and product development. CoVet is an AI-powered clinical co-pilot built for veterinary professionals. Osler, Hoskin & Harcourt LLP...

Lead Office: Toronto Date Announced: September 2, 2025 Value: --

Impact America Fund in connection with Nest Health's $12.5-million Series A round

On August 25, 2025, Nest Health announced that it raised $12.5 million in a Series A financing round. New investors in this round included Impact America Fund, Hopelab, University Growth Fund, Luminary Impact Fund and Socium Ventures. The company plans to use this funding towards advancing its...

Lead Office: Toronto Date Announced: August 25, 2025 Value: $12.5 million

Inovia Capital in connection with Cavelo’s $5-million Seed Extension round

On July 29, 2025, Cavelo Inc. announced that it secured $5 million in a Seed Extension round led by Inovia. Cavelo Inc. plans to focus on its sales, marketing and developing its product. Inovia Capital is a Montréal-based venture capital firm specializing in investments in technology...

Lead Office: Toronto Date Announced: July 29, 2025 Value: $5 million